An Crepel Belgian Reimbursement Update – July 2026 Targeted access gains, tighter legacy routes The July 2026 update shows three clear signals. First, access broadening continues in selected high-need and specialist-driven areas, particularly in infla... Jun 28, 2026 Farmanaut Market Access Insights
An Crepel Belgian Reimbursement Update – June 2026 Selected access changes across key treatment areas June 2026 brings a diverse Belgian reimbursement update, with relevant patient access changes across osteoporosis, rare diseases, vaccines, oncology,... May 28, 2026 Farmanaut Market Access Insights
An Crepel Belgian Reimbursement Update - May 2026 Immuno-oncology, hATTR and neurology stand out The Belgian reimbursement update effective 1 May 2026 is a broad one, but not every change carries the same market access signal. Several updates are adm... Apr 27, 2026 Farmanaut Market Access Insights
